Pirruccello, James P. http://orcid.org/0000-0001-6088-4037
Di Achille, Paolo http://orcid.org/0000-0001-9256-0678
Choi, Seung Hoan http://orcid.org/0000-0002-2797-3190
Rämö, Joel T.
Khurshid, Shaan
Nekoui, Mahan http://orcid.org/0000-0001-7466-4801
Jurgens, Sean J. http://orcid.org/0000-0002-1605-9782
Nauffal, Victor http://orcid.org/0000-0001-7199-299X
Kany, Shinwan
,
Ng, Kenney http://orcid.org/0000-0003-0792-070X
Friedman, Samuel F. http://orcid.org/0000-0002-0688-2169
Batra, Puneet http://orcid.org/0000-0001-6822-0593
Lunetta, Kathryn L. http://orcid.org/0000-0002-9268-810X
Palotie, Aarno http://orcid.org/0000-0002-2527-5874
Philippakis, Anthony A. http://orcid.org/0000-0001-6953-3794
Ho, Jennifer E. http://orcid.org/0000-0002-7987-4768
Lubitz, Steven A. http://orcid.org/0000-0002-9599-4866
Ellinor, Patrick T. http://orcid.org/0000-0002-2067-0533
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K08HL159346)
Article History
Received: 3 September 2021
Accepted: 24 April 2024
First Online: 21 May 2024
Competing interests
: Dr. Pirruccello has served as a consultant for Maze Therapeutics. Dr. Lubitz is an employee of Novartis as of July 2022. Dr. Lubitz received sponsored research support from Bristol Myers Squibb, Pfizer, Boehringer Ingelheim, Fitbit, Medtronic, Premier, and IBM, and has consulted for Bristol Myers Squibb, Pfizer, Blackstone Life Sciences, and Invitae. Dr. Ng is employed by IBM Research. Dr. Ho is supported by a grant from Bayer AG focused on machine learning and cardiovascular disease and a research grant from Gilead Sciences. Dr. Ho has received research supplies from EcoNugenics. Dr. Philippakis is employed as a Venture Partner at GV; he is also supported by a grant from Bayer AG to the Broad Institute focused on machine learning for clinical trial design. Dr. Ellinor is supported by a grant from Bayer AG to the Broad Institute focused on the genetics and therapeutics of cardiovascular diseases. Dr. Ellinor has also served on advisory boards or consulted for Bayer AG, Quest Diagnostics, MyoKardia and Novartis. The remaining authors report no disclosures.